Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vosevi
Pharma
AbbVie, Biogen, UCB, AstraZeneca and more—News of Note
We may be focusing on our forecasts for the year ahead with today's issue, but here's some Friday news we thought you shouldn't miss.
Angus Liu
Dec 20, 2019 8:31am
FDA flags liver risks for AbbVie, Merck, Gilead hep C meds
Aug 29, 2019 10:45am
AbbVie's latest hep C ads highlight Mavyret's time-to-cure edge
Dec 12, 2018 11:10am
Gilead gets its go-ahead for blockbuster hopeful Vosevi
Jul 19, 2017 11:15am
